Initial Statement of Beneficial Ownership (3)
2022年11月4日 - 06:04AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP
OF SECURITIES
|
OMB
APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5 |
|
Filed pursuant to Section 16(a) of the
Securities Exchange Act of 1934 or Section 30(h) of the Investment
Company Act of 1940
|
|
1. Name
and Address of Reporting Person * McQuarrie David
P. |
2. Date of Event Requiring Statement
(MM/DD/YYYY)
11/1/2022
|
3. Issuer Name and Ticker or Trading
Symbol HP INC [HPQ] |
(Last)
(First)
(Middle)
C/O HP INC., 1501 PAGE MILL RD |
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)_____
Director _____
10% Owner
___X___ Officer (give title
below) _____
Other (specify below)
Chief Commercial Officer / |
(Street)
PALO
ALTO, CA 94304
(City)
(State)
(Zip)
|
5. If Amendment, Date Original
Filed(MM/DD/YYYY)
|
6. Individual or Joint/Group
Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially
Owned
|
1.Title of Security
(Instr. 4) |
2. Amount of Securities Beneficially Owned
(Instr. 4) |
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) |
4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
Common Stock |
7147 |
D |
|
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible
securities)
|
1. Title of Derivate Security
(Instr. 4) |
2. Date Exercisable and Expiration Date
(MM/DD/YYYY) |
3. Title and Amount of Securities Underlying
Derivative Security
(Instr. 4) |
4. Conversion or Exercise Price of Derivative
Security |
5. Ownership Form of Derivative Security: Direct (D)
or Indirect (I)
(Instr. 5) |
6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Employee Stock Options (right to buy) |
(1) |
10/30/2029 |
Common Stock |
86364 (1) |
$17.37 |
D |
|
Restricted Stock Units |
(2) |
(2) |
Common Stock |
12496.26 (2) |
(3) |
D |
|
Restricted Stock Units |
(4) |
(4) |
Common Stock |
3967 (4) |
(3) |
D |
|
Restricted Stock Units |
(5) |
(5) |
Common Stock |
20851.94 (5) |
(3) |
D |
|
Restricted Stock Units |
(6) |
(6) |
Common Stock |
25790.02 (6) |
(3) |
D |
|
Restricted Stock Units |
(7) |
(7) |
Common Stock |
27646.95 (7) |
(3) |
D |
|
Explanation of
Responses: |
(1) |
On 10/31/2019, the reporting
person was granted options to purchase 86,364 shares of HP common
stock, all of which vested annually over 3 years on the anniversary
of the grant date. |
(2) |
On 12/6/2019, the reporting
person was granted 34,146 restricted stock units ("RSUs"), 1/3 of
which vest annually over 3 years on the anniversary of 12/7/2019.
Dividend equivalent rights accrue with respect to these RSUs when
and as dividends are paid on HP common stock. The number of
derivative securities in column 3 includes 1,114.26 dividend
equivalent units. |
(3) |
Each RSU represents a
contingent right to receive one share of HP common
stock. |
(4) |
On 10/29/2020, the reporting
person was granted 11,249 RSUs, 1/3 of which vest annually over 3
years on the anniversary of the grant date. Dividend equivalent
rights accrue with respect to these RSUs when and as dividends are
paid on HP common stock. The number of derivative securities in
column 3 includes 217 dividend equivalent units. |
(5) |
On 12/7/2020, the reporting
person was granted 29,561 RSUs, 1/3 of which vest annually over 3
years on the anniversary of the grant date. Dividend equivalent
rights accrue with respect to these RSUs when and as dividends are
paid on HP common stock. The number of derivative securities in
column 3 includes 1,143.94 dividend equivalent units. |
(6) |
On 2/10/2021, the reporting
person was granted 36,832 RSUs, 1/3 of which vest annually over 3
years on the anniversary of the grant date. Dividend equivalent
rights accrue with respect to these RSUs when and as dividends are
paid on HP common stock. The number of derivative securities in
column 3 includes 1,235.02 dividend equivalent units. |
(7) |
On 12/7/2021, the reporting
person was granted 26,817 RSUs, 1/3 of which vest annually over 3
years on the anniversary of the grant date. Dividend equivalent
rights accrue with respect to these RSUs when and as dividends are
paid on HP common stock. The number of derivative securities in
column 3 includes 829.95 dividend equivalent units. |
Reporting
Owners
|
Reporting Owner Name / Address |
Relationships
|
Director |
10% Owner |
Officer |
Other |
McQuarrie David P.
C/O HP INC.
1501 PAGE MILL RD
PALO ALTO, CA 94304 |
|
|
Chief Commercial Officer |
|
Signatures
|
/s/ Rick Hansen as Attorney-in-Fact for David P.
McQuarrie |
|
11/3/2022 |
**Signature of Reporting
Person |
Date |
Reminder: Report on a separate line for each class
of securities beneficially owned directly or
indirectly. |
* |
If the form is filed by more than one
reporting person, see Instruction 5(b)(v). |
** |
Intentional misstatements or omissions
of facts constitute Federal Criminal Violations. See 18
U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: |
File three copies of this Form, one of
which must be manually signed. If space is insufficient, see
Instruction 6 for procedure. |
Persons who respond to the collection of information
contained in this form are not required to respond unless the form
displays a currently valid OMB control number. |
HP (NYSE:HPQ)
過去 株価チャート
から 12 2022 まで 1 2023
HP (NYSE:HPQ)
過去 株価チャート
から 1 2022 まで 1 2023